DHDDS anticorps (N-Term)
Aperçu rapide pour DHDDS anticorps (N-Term) (ABIN631604)
Antigène
Voir toutes DHDDS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- DHDDS antibody was raised against the N terminal of DHDDS
-
Purification
- Affinity purified
-
Immunogène
- DHDDS antibody was raised using the N terminal of DHDDS corresponding to a region with amino acids NRRYAKKCQVERQEGHSQGFNKLAETLRWCLNLGILEVTVYAFSIENFKR
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
DHDDS Blocking Peptide, (ABIN5613188), is also available for use as a blocking control in assays to test for specificity of this DHDDS antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DHDDS antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DHDDS (Dehydrodolichyl Diphosphate Synthase (DHDDS))
-
Autre désignation
- DHDDS
-
Sujet
- Dehydrodolichyl diphosphate (dedol-PP) synthase catalyzes cis-prenyl chain elongation to produce the polyprenyl backbone of dolichol, a glycosyl carrier lipid required for the biosynthesis of several classes of glycoproteins.
-
Poids moléculaire
- 39 kDa (MW of target protein)
Antigène
-